VJOncology is committed to improving our service to you

ASCO 2020 | Revisiting farnesyltransferase inhibitors for head and neck cancer

VJOncology is committed to improving our service to you

Jared Weiss

Jared Weiss, MD, of UNC Lineberger, Chapel Hill, NC, discusses the use of tipifarnib, a farnesyltransferase inhibitor, in HRAS mutated head and neck cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter